5-Amino-1MQ

5-Amino-1MQ develop for researchers pushing the boundaries of metabolic and longevity science, 5-AMINO-1MQ 10MG is a precision-grade small molecule inhibitor of nicotinamide N-methyltransferase (NNMT). Sourced by ThePeptideLabs in Canada and delivered in a 10mg lyophilized powder format at 99% purity, this compound offers the consistency and reliability that rigorous laboratory work demands. By selectively inhibiting NNMT — an enzyme central to energy regulation and fat metabolism — this compound has demonstrated, in preclinical studies, the capacity to elevate intracellular NAD⁺ and SAM levels, suppress lipid accumulation in adipocytes, and reduce white adipose tissue mass in diet-induced obese mouse models.

The primary mechanism of 5-AMINO-1MQ 10MG involves the potent, selective inhibition of the NNMT enzyme, which is often overexpressed in metabolic disorders. By blocking this enzyme, researchers can observe a significant shift in cellular methyl-donor availability. This inhibition prevents the conversion of nicotinamide into 1-methylnicotinamide, effectively “rescuing” the NAD⁺ salvage pathway. In advanced cellular assays, this has been shown to increase mitochondrial biogenesis and enhance the sirtuin-mediated stress response, as documented in prominent metabolic research databases.

Metabolic health: Preclinical data indicate that NNMT inhibition may reduce fat cell size and support improved insulin sensitivity and glucose tolerance in diet-induced obesity models.
Weight regulation: In mouse studies, systemic administration produced a progressive reduction in body weight and up to a ~35% decrease in white adipose tissue mass.
NAD⁺ and energy metabolism: Shown to increase intracellular NAD⁺ levels by up to 1.6-fold, supporting mitochondrial function and cellular energy production.
Anti-aging and longevity research: Elevated NAD⁺ availability is associated with reduced age-related cellular decline and improved muscle stem cell regenerative capacity.
Lipogenesis inhibition: Concentrations of 30–60µM reduced lipid accumulation in pre-adipocytes by 50–70% in controlled cell studies.
A defining characteristic of this research molecule is its high membrane permeability and metabolic stability. Unlike larger peptides, this small molecule can rapidly traverse the lipid bilayer of adipocytes to engage its intracellular target. Mapping these pathways allows researchers to gain a deeper understanding of cellular resilience and structural preservation over multi-day periods. To maintain the highest data fidelity, researchers should cross-reference their batches with our extensive peptide library to ensure consistency across comparative longevity studies.